Bray, J. P., & Munday, J. S. (2020). Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma. MDPI AG.
Chicago Style (17th ed.) CitationBray, Jonathan P., and John S. Munday. Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma. MDPI AG, 2020.
MLA (9th ed.) CitationBray, Jonathan P., and John S. Munday. Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.